{
    "items": [
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/nucleome-therapeutics-announces-a-strategic-collaboration-with-johnson-johnson-to-map-genetic-associations-linked-to-autoimmune-disease\" title=\"Nucleome Therapeutics announces a strategic collaboration with Johnson &amp; Johnson to map genetic associations linked to autoimmune disease\" class=\"state-published\">Nucleome Therapeutics announces a strategic collaboration with Johnson &amp; Johnson to map genetic associations linked to autoimmune disease</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">21 October 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Nucleome Therapeutics (\u2018Nucleome\u2019 or \u2018the Company\u2019), a biotechnology company using 3D genomics to discover precision medicines for complex diseases, announces today it has entered a research collaboration with Johnson &amp; Johnson*.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/internationally-renowned-academic-lee-sweetlove-joins-moa\" title=\"Internationally renowned academic Lee Sweetlove joins Moa\" class=\"state-published\">Internationally renowned academic Lee Sweetlove joins Moa</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">15 October 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Moa Technology is pleased to announce that Lee Sweetlove, Professor of Plant Sciences at the University of Oxford, has joined our team. Professor Sweetlove will be working to further understanding of the novel herbicidal modes of action discovered by Moa, which we are currently developing into safe, effective and affordable solutions to protect harvests from crop-killing weeds.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa2019s-ground-breaking-science-features-in-journal-weed-science\" title=\"Moa\u2019s groundbreaking science features in journal Weed Science\" class=\"state-published\">Moa\u2019s groundbreaking science features in journal Weed Science</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">9 October 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Breaking the 30 year impasse in novel herbicide discovery.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/enara-bio-raises-32-5-million-series-b-financing-to-advance-first-in-class-pipeline-of-tcr-based-immunotherapies-targeting-novel-dark-antigens\" title=\"Enara Bio raises $32.5M Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens\u00ae\" class=\"state-published\">Enara Bio raises $32.5M Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens\u00ae</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">2 October 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Enara Bio today announces the closing of a $32.5M Series B financing supported by a strong syndicate of new and existing biotech investors. The round was co-led by new investors, Pfizer Ventures and M Ventures, with participation from all existing investors, including RA Capital, Samsara BioCapital and SV Health Investors.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/omass-therapeutics-expands-development-team-with-key-appointments-in-us-and-uk-and-announces-the-nomination-of-clinical-candidate-against-mc2\" title=\"OMass Therapeutics expands development team with key appointments in US and UK and announces the nomination of clinical candidate against MC2\" class=\"state-published\">OMass Therapeutics expands development team with key appointments in US and UK and announces the nomination of clinical candidate against MC2</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">30 September 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">OMass Therapeutics (\u2018OMass\u2019 or \u2018the Company\u2019), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the candidate nomination of its lead program targeting the melanocortin-2 (MC2) receptor and key appointments to support its progress towards becoming a clinical-stage company.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa-and-biomar-announce-bio-herbicide-collaboration\" title=\"Moa and Biomar announce bio-herbicide collaboration\" class=\"state-published\">Moa and Biomar announce bio-herbicide collaboration</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">16 September 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Moa has boosted its bio-herbicide research and development programme with a new long-term collaboration agreement with Biomar Microbial Technologies.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alchemab-appoints-co-founder-jane-osbourn-as-chief-executive-officer\" title=\"Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer\" class=\"state-published\">Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">11 September 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Alchemab Therapeutics (Alchemab), a pharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient individuals, today announces that Jane Osbourn, OBE, FMEDSCI, PhD, Alchemab\u2019s Chief Scientific Officer (CSO), has succeeded Young Kwon, PhD as Chief Executive Officer (CEO) and member of the Board.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/cardiatec-secures-6-5m-seed-funding-to-advance-its-multi-omics-drug-discovery-platform-for-cardiovascular-diseases\" title=\"CardiaTec secures $6.5M seed funding to advance its multi-omics drug discovery platform for cardiovascular diseases\" class=\"state-published\">CardiaTec secures $6.5M seed funding to advance its multi-omics drug discovery platform for cardiovascular diseases</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">9 September 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">CardiaTec, a TechBio company employing computational methods to decode the biology behind cardiovascular disease, has secured $6.5M in seed funding led by Montage Ventures with participation from Laidlaw Scholars Ventures, Apex Ventures, and Continuum Health Ventures.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa-announces-international-field-trial-success-at-the-acs-autumn-conference-in-denver\" title=\"Moa announces international field trial success at the ACS autumn conference in Denver\" class=\"state-published\">Moa announces international field trial success at the ACS autumn conference in Denver</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">19 August 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Oxford University spin-out Moa Technology has announced excellent results in multi-country field trials of promising new classes of herbicide with novel modes of action recently discovered by the company.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/cyanocapture-continues-to-make-strides-in-the-green-sciences-industry\" title=\"CyanoCapture continues to make strides in the green sciences industry\" class=\"state-published\">CyanoCapture continues to make strides in the green sciences industry</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">11 August 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">CyanoCapture was selected as one of the two winners of the Green Sciences Incubator challenge, which L'Or\u00e9al organised in collaboration with Genopole and Hello Tomorrow.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/nucleome-therapeutics-appoints-mark-bodmer-as-chief-executive-officer\" title=\"Nucleome Therapeutics appoints Mark Bodmer as Chief Executive Officer\" class=\"state-published\">Nucleome Therapeutics appoints Mark Bodmer as Chief Executive Officer</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">15 July 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Nucleome Therapeutics (\u2018Nucleome\u2019 or \u2018the Company\u2019), a biotechnology company using spatial genomics to discover precision medicines for complex diseases, announces today that it has appointed Dr. Mark Bodmer as Chief Executive Officer with effect from 24 July.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa-harvests-global-deal-for-new-herbicide\" title=\"Moa harvests global deal for new herbicide\" class=\"state-published\">Moa harvests global deal for new herbicide</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">7 July 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Agricultural biotech firm Moa Technology has signed a research and commercial partnership with Nufarm, a global agricultural innovator based in Melbourne, Australia.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/gsk-enters-into-a-multi-year-data-licence-agreement-with-ochre-bio-to-further-investigate-the-drivers-of-liver-disease\" title=\"GSK enters into a multi-year data licence agreement with Ochre Bio to further investigate the drivers of liver disease\" class=\"state-published\">GSK enters into a multi-year data licence agreement with Ochre Bio to further investigate the drivers of liver disease</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">11 June 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Ochre and GSK will create a foundational liver biology dataset that could have the potential to further improve translation of novel therapies for liver diseases.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alchemab-advances-a-novel-antibody-with-potential-in-parkinsons-disease-with-support-from-the-michael-j-fox-foundation\" title=\"Alchemab advances a novel antibody with potential in Parkinson\u2019s disease with support from The Michael J. Fox Foundation\" class=\"state-published\">Alchemab advances a novel antibody with potential in Parkinson\u2019s disease with support from The Michael J. Fox Foundation</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">5 June 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Former BioEscalator tenant Alchemab Therapeutics continues to make significant strides in Parkinson's disease research, recently receiving a substantial grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to advance its innovative antibody discovery program.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/cardiatec-joins-the-bioescalator-ai-in-cardiovascular-drug-discovery\" title=\"CardiaTec joins the BioEscalator - AI in cardiovascular drug discovery\" class=\"state-published\">CardiaTec joins the BioEscalator - AI in cardiovascular drug discovery</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">17 April 2024</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">The BioEscalator welcomes CardiaTec, a spin-out company from the University of Cambridge that employs computational methods to decode the biology behind cardiovascular disease.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/ochre-bio-outgrows-the-bioescalator\" title=\"Ochre Bio outgrows the BioEscalator\" class=\"state-published\">Ochre Bio outgrows the BioEscalator</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">27 October 2022</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">With Ochre Bio's chemistry laboratory housed at The Oxford Science Park, it was a no-brainer for the company to move over to the park when it outgrew the BioEscalator.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/the-bioescalator-bids-farewell-to-nucleome-therapeutics\" title=\"The BioEscalator bids farewell to Nucleome Therapeutics\" class=\"state-published\">The BioEscalator bids farewell to Nucleome Therapeutics</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">26 September 2022</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Nucleome Therapeutics has outgrown its space at the BioEscalator and moved to pastures new. The company will continue its growth journey at The Oxford Science Park.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/pepgen-graduates-from-the-bioescalator\" title=\"PepGen graduates from the BioEscalator\" class=\"state-published\">PepGen graduates from the BioEscalator</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">31 July 2022</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">PepGen is the last of the original cohort of companies that moved into the BioEscalator when it first opened. The new PepGen headquarters in Boston, USA, will manage late-stage preclinical testing and clinical and regulatory functions.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/introducing-theraport\" title=\"Introducing Theraport\" class=\"state-published\">Introducing Theraport</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">30 June 2022</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">Winner of OUBT's Biohackathon 2022, part of the Oxford Catalyse Programme, Theraport join the BioEscalator community for three months.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-search\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n        \n        <div class=\"media-body\">\n        \n            <h4 class=\"media-heading\">\n                <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/cyanocapture-moves-on-from-the-bioescalator\" title=\"CyanoCapture moves on from the BioEscalator\" class=\"state-published\">CyanoCapture moves on from the BioEscalator</a>\n            </h4>\n            \n            \n                \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=alumni-news\" title=\"Alumni news\">\n\t\t                <span class=\"label label-primary\">Alumni news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.bioescalator.ox.ac.uk/search?category=bioescalator-news\" title=\"BioEscalator news\">\n\t\t                <span class=\"label label-primary\">BioEscalator news</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n            \n\n            \n                <p class=\"details\" itemprop=\"datePublished\">15 May 2022</p>\n            \n                            \n            \n                <p data-truncate=\"yes\" data-truncate-lines=\"2\">The company has moved into the newly refurbished Hayakawa Building at the Oxford Science Park.</p>\n            \n\n            \n                                \n        </div>\n        \n    </div>\n\n\n"
    ], 
    "more": "\n\n    \n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/introducing-medimab-biotherapeutics/search?category=alumni-news&amp;b_start:int=80&amp;tab=newsitem&amp;format=json&amp;random=b36fbbf7-f6d8-4ab0-9b6c-97cba6a96c33&amp;categories=alumni-news\" title=\"Load more\" class=\"btn btn-default load-more-button\">\n            Load More\n        </a>\n    \n\n", 
    "msg": ""
}